CAMKK2 and colorectal cancer: The study demonstrated that STO-609, an inhibitor of CaMKKβ, attenuated the autophagy effect of colorectal cancer cells mediated by NaB and decreased the activity of CaMKKβ, AMPKα, and ACC.